OverviewChartNewsTraderScreen

ZimVie Inc/  US98888T1079  /

IEX
5/21/2024  9:59:46 PM Chg. +0.27 Volume Bid- Ask- High Low
17.29USD +1.59% 5,629
Turnover: 97,142.09		 -Bid Size: - -Ask Size: - 17.37 16.73
GlobeNewswire 5/16 ZimVie to Participate in Upcoming Investor Conferences
GlobeNewswire 5/8 ZimVie Reports First Quarter 2024 Financial Results
GlobeNewswire 4/24 ZimVie to Report First Quarter Financial Results on May 8, 2024
GlobeNewswire 4/1 ZimVie Announces Closing of Sale of Spine Business
GlobeNewswire 3/27 ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire 2/28 ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 2/21 ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
GlobeNewswire 2/7 ZimVie Announces Launch of Next-Generation TSX® Implant in Japan
GlobeNewswire 12/18/2023 ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million
GlobeNewswire 12/12/2023 ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma...
GlobeNewswire 11/1/2023 ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
GlobeNewswire 10/31/2023 ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc
GlobeNewswire 10/24/2023 ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
GlobeNewswire 10/17/2023 ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
GlobeNewswire 10/11/2023 ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
GlobeNewswire 10/10/2023 ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
GlobeNewswire 9/26/2023 ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
GlobeNewswire 8/17/2023 ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
GlobeNewswire 3/1/2022 ZimVie Completes Separation from Zimmer Biomet; Announces Board of Directors